A. Jovaisas

发表

Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.

Jacques P. Brown, W. Leslie, J. Adachi, 2014, Canadian family physician Medecin de famille canadien.

Osteoporosis guideline implementation in family medicine using electronic medical records: Survey of learning needs and barriers.

L. Thabane, J. Pritchard, S. Karampatos, 2016 .

Positive effect of etidronate therapy is maintained after drug is terminated in patients using corticosteroids.

G. Ioannidis, I. Barton, A. Chines, 2001, Journal of clinical densitometry.

Use of corticosteroids in patients with rheumatoid arthritis treated with infliximab: treatment implications based on a real-world Canadian population

J. Sampalis, B. Haraoui, E. Rampakakis, 2015, RMD Open.

Acute gastrointestinal manifestations of systemic lupus erythematosus.

A. Jovaisas, G. Kraag, 1987, Canadian journal of surgery. Journal canadien de chirurgie.

Effectiveness and Safety of Tofacitinib in Canadian Patients With Rheumatoid Arthritis: Primary Results From a Prospective Observational Study

J. Sampalis, E. Keystone, S. Jamal, 2022, Arthritis care & research.

SAT0035 Variability in the Classification of Remission among Disease Activity Indices and Their Correlation: An Analysis From a Prospective, Observational Registry

M. Khraishi, C. Thorne, E. Rampakakis, 2013 .

Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial Spondyloarthritis

P. Rahman, R. Inman, M. Garrido-Cumbrera, 2022, The Journal of Rheumatology.

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis.

Jacques P. Brown, J. Adachi, J. Pope, 1997, The New England journal of medicine.

Open-label tolerability study of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis.

C. Bombardier, N. Bellamy, J. Esdaile, 1992, Current medical research and opinion.